Biomarker Analysis Revealed Distinct Profiles of Innate and Adaptive Immunity in Infants with Ocular Lesions of Congenital Toxoplasmosis

Table 1

Hematological records in infants with congenital toxoplasmosis*.

Parameters	NI; ()	TOXO; ()	TOXO subgroups
			NRL; ()	ARL; ()	ACRL; ()	CRL; ()
WBC	9.3 (5.3–17.3) × 10^3	11.6 (5.6–22.9) × 10^3	11.0 (6.2–17.3) × 10^3	14.5 (7.6–23.0) × 10^3	11.8 (5.7–19.4) × 10^3	11.2 (5.7–18.2) × 10^3
Monocytes	0.8 (0.1–1.9) × 10^3	1.2 (0.1–2.3) × 10^3	1.1 (0.2–2.1) × 10^3	1.4 (0.5–1.7) × 10^3	1.3 (0.2–2.3) × 10^3	1.0 (0.1–2.4) × 10^3
Neutrophils	1.8 (0.7–4.0) × 10^3	1.7 (0.5–5.7) × 10^3	1.8 (1.0–3.0) × 10^3	1.7 (0.8–3.6) × 10^3	1.6 (0.4–5.3) × 10^3	1.6 (0.9–5.7) × 10^3
Lymphocytes	6.2 (3.9–14.2) × 10^3	7.5 (1.0–18.8) × 10^3	7.3 (4.3–14.2) × 10^3	8.5 (5.4–18.1) × 10^3	7.5 (3.9–13.9) × 10^3	7.4 (1.0–13.9) × 10^3
Eosinophils	0.4 (0.1–0.8) × 10^3	0.4 (0.1–1.7) × 10^3	0.4 (0.08–0.8) × 10^3	0.5 (0.2–1.1) × 10^3	0.4 (0.003–1.7) × 10^3	0.3 (0.06–1.1) × 10^3
RBC	3.5 (2.8–4.5) × 10^6	3.6 (2.9–5.1) × 10^6	3.5 (2.5–4.4) × 10^6	3.68 (3.1–4.1) × 10^6	3.5 (2.4–4.5) × 10^6	3.71 (2.5–4.2) × 10^6
Hb (g/dL)	10.8 (8.5–13.1)	10.5 (8.1–13.9)	10.3 (7.8–13.0)	10.8 (8.3–12.2)	9.9 (7.7–12.9)	10.75 (7.2–12.9)
Hct (%)	31.0 (25.4–39.4)	31.9 (22.1–45.4)	30.6 (23.0–39.1)	32.8 (27.1–37.3)	29.4 (20.8–37.7)	31.8 (23.0–36.9)
PLT	4.8 (1.3–7.3) × 10^5	3.8 (1.1–7.9) × 10^5	4.31 (1.4–6.7) × 10^5	3.35 (1.4–6.3) × 10^5	3.61 (1.4–6.3) × 10^5	2.87 (1.7–4.9) × 10^5

WBC = white blood cells; RBC = red blood cells; PLT = platelets. Results are expressed in cell counts/mm³. Significant differences at are highlighted by bold format.